Date: 2017-05-03
Type of information: Establishment of a new subsidiary in the EU
Compound: new office in Athens
Company: Swedish Orphan Biovitrum - SOBI (Sweden)
Therapeutic area: Rare diseases - Genetic diseases
Type agreement: establishment of a new subsidiary in the EU
Action mechanism:
Disease:
Details:
- • On May 3, 2017, Swedish Orphan Biovitrum (Sobi™) has formally opened a new office in Athens, Greece. The launch event will start with a ribbon cutting ceremony in Aegli Zappeiou. “Our Athens office will enable expanding access to innovative treatments and we aim through close dialogue and cooperation with the Greek authorities to provide high quality care and sustainable access to treatment for people living with rare diseases in Greece”, says Sergio Lai, General Manager Sobi, Italy, Greece, Cyprus and Malta.
Financial terms:
Latest news:
Is general: Yes
